Testing Demand Before Perfecting Technology: Interview with Eyebot CEO Matthias Hofmann

About this episode

Matthias Hofmann discusses Eyebot's strategy and insights on fundraising and product development.

In this episode of Medsider Radio , we sat down with Matthias Hofmann , CEO of Eyebot . Eyebot is commercializing retail kiosks that deliver quick, efficient vision testing. Before Eyebot, Matthias led product development at Formlabs and served as an R&D lead at EyeNetra, where he helped bring the first smartphone-based vision test to market. He holds a Ph.D. in Electrical Engineering with graduate work in vision science and optics. In this interview, Matthias discusses how early missteps informed Eyebot's strategy, how he proved demand before raising capital, and how iterative clinical studies established commercial credibility — along with his unconventional advice on fundraising. Before we dive into the discussion, I wanted to mention a few things: First, if you’re into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter. And if you’re ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization…

People in this episode

Host: Scott Nelson

Guest: Matthias Hofmann

Topics covered

• vision testing
• medtech
• entrepreneurship
• fundraising
• product development

Keywords

• Eyebot
• vision testing kiosks
• fundraising
• clinical studies
• medtech

Mentioned in this episode

Organizations: Eyebot, Formlabs, EyeNetra

Places: Medsider

More episodes of Medsider: Learn from Medtech and Healthtech Founders and CEOs

• Building Clinical Evidence Around Your Target Market: Interview with Teal Health CEO Kara Egan · June 8, 2026 · 56 min
• Solving for Healthcare’s Broken Doorway: Interview with OnMed CEO Karthik Ganesh · June 1, 2026 · 51 min
• Meeting Patients Where They Are: Interview with Clairity CEO Dr. Connie Lehman · May 26, 2026 · 50 min
• Translating Academic IP into a Medtech Startup: Interview with Echopoint Medical CEO Antony Odell · May 18, 2026 · 52 min
• Why Early Revenue is the Most Credible Proof in Medtech: Interview with restor3d CEO Kurt Jacobus · May 12, 2026 · 55 min
• Finding the Clinical Need Hiding in Plain Sight: Interview with LightForce CEO Alfred Griffin · May 4, 2026 · 51 min